Compare fund portfolios
See how two funds' portfolios overlap. Enter two tickers:
ETNHX vs LABU
Shared holdings
25
ETNHX covered by LABU
17.52%
LABU covered by ETNHX
17.52%
Coverage = share of one portfolio's weight reproduced by the other (overlapping positions, min weight). Top 50 positions per side shown; = held by both — hover a shared position to highlight it in both columns.
ETNHX (March 31, 2026)
| Security | Weight | |
|---|---|---|
| GUARDANT HEALTH INC | 4.10% | |
| MIRUM PHARMACEUTICALS INC | 4.05% | |
| INSMED INC | 3.81% | |
| US BANK MMDA - USBGFS 9 | 3.67% | |
| BELITE BIO INC | 3.32% | |
| KYMERA THERAPEUTICS INC | 3.31% | |
| VAXCYTE INC | 3.05% | |
| APOGEE THERAPEUTICS INC | 2.97% | |
| IONIS PHARMACEUTICALS INC | 2.74% | |
| ARGENX SE SPONSORED ADR | 2.28% | |
| Abivax SA SPONSORED ADS | 2.26% | |
| SCHOLAR ROCK HOLDING CORP | 2.24% | |
| CELLDEX THERAPEUTICS INC | 2.09% | |
| IRHYTHM TECHNOLOGIES INC | 2.08% | |
| BRIDGEBIO PHARMA INC | 2.06% | |
| CYTOKINETICS INC | 2.00% | |
| TREVI THERAPEUTICS INC | 1.98% | |
| PALVELLA THERAPEUTICS INC | 1.83% | |
| CELCUITY INC | 1.76% | |
| KESTRA MEDICAL T | 1.73% | |
| AXSOME THERAPEUTICS INC | 1.71% | |
| MBX BIOSCIENCES INC | 1.68% | |
| CENTESSA PHARMACEUTICALS LTD ADR | 1.68% | |
| SIONNA THERAPEUTICS INC | 1.64% | |
| DISC MEDICINE INC | 1.60% | |
| FIRST AMERICAN GOVERNMENT OBLIGATIONS FUND - CLASS U | 1.59% | |
| REVOLUTION MEDICINES INC | 1.59% | |
| CG ONCOLOGY INC | 1.57% | |
| IMMIX BIOPHARMA INC | 1.47% | |
| ARROWHEAD PHARMACEUTICALS INC | 1.47% | |
| EVOMMUNE INC | 1.37% | |
| ADC Therapeutics SA SHS | 1.36% | |
| AMYLYX PHARMACEUTICALS INC | 1.33% | |
| BETA BIONICS INC | 1.30% | |
| NURIX THERAPEUTICS INC | 1.28% | |
| DIANTHUS THERAPEUTICS INC | 1.20% | |
| SUTRO BIOPHARMA INC | 1.13% | |
| HEARTFLOW INC | 1.10% | |
| UNITED THERAPEUTICS CORP DEL | 1.06% | |
| Avalyn Pharma | 1.03% | |
| EYEPOINT PHARMACEUTICALS INC | 1.02% | |
| DEXCOM INC | 1.01% | |
| GENEDX HOLDINGS CORP-A | 0.99% | |
| OVID THERAPEUTIC | 0.99% | |
| GLAUKOS CORP | 0.97% | |
| PRIVIA HEALTH GROUP INC | 0.96% | |
| DEFINIUM THERAPEUTICS INC | 0.82% | |
| PRAXIS PRECISION MEDICINES INC | 0.78% | |
| ORIC PHARMACEUTICALS INC | 0.76% | |
| INVIVYD INC | 0.75% |
LABU (April 30, 2026)
| Security | Weight | |
|---|---|---|
| DREYFUS GOVT CASH MGMT FUND | 7.43% | |
| US ULTRA BOND CBT Sep25 | 7.26% | |
| GOLDMAN FINL SQ TRSRY INST 506 | 6.27% | |
| GOLDMAN SACHS FIN GOV 465 INSTITUT | 1.71% | |
| APELLIS PHARMACEUTICALS INC | 1.44% | |
| REVOLUTION MEDICINES INC | 1.27% | |
| TRAVERE THERAPEUTICS INC | 1.25% | |
| ARROWHEAD PHARMACEUTICALS INC | 1.11% | |
| TWIST BIOSCIENCE CORP | 1.10% | |
| SUMMIT THERAPEUTICS INC | 1.09% | |
| ALKERMES PLC | 1.07% | |
| TG THERAPEUTICS INC | 1.06% | |
| MADRIGAL PHARMACEUTICALS INC | 1.06% | |
| BEAM THERAPEUTICS INC | 1.02% | |
| APOGEE THERAPEUTICS INC | 0.98% | |
| SCHOLAR ROCK HOLDING CORP | 0.95% | |
| PRAXIS PRECISION MEDICINES INC | 0.95% | |
| EXELIXIS INC | 0.94% | |
| MIRUM PHARMACEUTICALS INC | 0.93% | |
| UNITED THERAPEUTICS CORP DEL | 0.92% | |
| NATERA INC | 0.92% | |
| CELCUITY INC | 0.92% | |
| CRISPR Therapeutics A.G. Series A | 0.92% | |
| KRYSTAL BIOTECH INC | 0.91% | |
| PROTAGONIST THERAPEUTICS INC | 0.90% | |
| NEUROCRINE BIOSCIENCES INC | 0.89% | |
| INCYTE CORP | 0.89% | |
| CG ONCOLOGY INC | 0.89% | |
| CYTOKINETICS INC | 0.89% | |
| NUVALENT INC-A | 0.88% | |
| IONIS PHARMACEUTICALS INC | 0.88% | |
| BRIDGEBIO PHARMA INC | 0.88% | |
| VAXCYTE INC | 0.88% | |
| KYMERA THERAPEUTICS INC | 0.88% | |
| BIOGEN INC | 0.87% | |
| COGENT BIOSCIENCES INC | 0.87% | |
| PTC THERAPEUTICS INC | 0.87% | |
| INSMED INC | 0.86% | |
| ALNYLAM PHARMACEUTICALS INC | 0.85% | |
| ROIVANT SCIENCES | 0.85% | |
| HALOZYME THERAPEUTICS INC | 0.84% | |
| ARCUTIS BIOTHERAPEUTICS INC | 0.83% | |
| SPYRE THERAPEUTICS INC | 0.83% | |
| SOLENO THERAPEUTICS INC | 0.82% | |
| ABBVIE INC | 0.82% | |
| AMGEN INC | 0.81% | |
| REGENERON PHARMACEUTICALS INC | 0.80% | |
| ULTRAGENYX PHARMA INC | 0.80% | |
| ACADIA PHARMACEUTICALS INC | 0.80% | |
| RHYTHM PHARMACEUTICALS INC | 0.80% |
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.